NYSE$AMC

AMC Entertainment Holdings Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

AMC's second quarter results for 2020 were reported.

AMC Entertainment Holdings, Inc. reported a challenging second quarter due to the suspension of operations at all domestic and international theatres in response to COVID-19 safety concerns. The company focused on reducing operating and capital expenditures, strengthening its liquidity position, and setting plans for the successful reopening of theatres.

  • AMC suspended operations at all domestic and international theatres.
  • AMC reduced global cash outlays by between 80% and 90% through stringent expense controls and cash management.
  • AMC raised $500 million from the issuance of new publicly-traded debt.
  • AMC devised AMC Safe & Clean protocols which put the company in a position to reopen its theatres as safely and responsibly as possible.

Headline financials

Total Revenue

$18.9M

Previous: $1.51B-98.7%
EPS (adj)

-$54.40

Previous: $1.70-3300.0%
Free Cash Flow

-$561M

Previous: $49.4M-1236.0%
Net Income

-$561M

Previous: $49.4M-1236.0%
Operating Income

-$472M

Previous: $106M-547.0%
Gross Profit

$18.9M

Previous: $947M-98.0%
Cash & Equivalents

$498M

Previous: $191M+161.4%
Total Assets

$11.3B

Previous: $13.5B-16.6%
Stock-Based Comp

$3.7M

Previous: $5.4M-31.5%

Revenue & EPS history

AMC · Revenue · Quarterly

$18.9M

Q2 2020-98.7%vs Q2 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

AMC · $1.3M total across 2 segments · Q2 2020

  • Admissions
    $900K
  • Food & Beverage
    $400K

Forward guidance

AMC is taking steps to optimize the health and safety of guests and associates while profitably resuming operations, including consulting with experts, establishing a protocol partnership, educating guests, implementing marketing, and reducing cost structure.

Tailwinds

  • Consulting with current and former faculty from the prestigious Harvard University School of Public Health to seek guidance from the best scientists and experts on how to create a safe environment for our guests and associates.
  • Personal protection equipment, cleaning protocols, limited theatre capacity, blocked seating, and other strategies are all being planned.
  • Employing high tech solutions, to aid in our sanitization procedures including the use of electrostatic sprayers, HEPA vacuums and wherever possible, significantly upgraded MERV 13 air ventilation filters.
  • Establishing a protocol partnership with The Clorox Company (NYSE:CLX) and have been advised as to how we can make our theatre environments as clean as possible.
  • Educating our guests so that they understand the actions we are taking with their safety in mind.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.9%

Avg return

Earnings day

+2.6%

Avg return

5 days after

+11.8%

Avg return

30 days after

33%

13 / 39 earnings

Positive

+31.1%

Q4 2019

Best reaction

-14.8%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+10.4%+4.2%+35.4%
Q4 2025-1.7%-3.3%-17.5%
Q3 2025+3.2%-2.8%-9.2%
Q1 2025-0.4%+1.1%+25.5%
Q4 2024-0.3%-6.7%-11.9%
Q3 2024-1.8%+2.3%+7.7%
Q2 2024-3.9%-5.9%-5.9%
Q1 2024-4.1%+62.7%+53.9%
Q4 2023-9.8%-10.2%-22.7%
Q3 2023-14.8%-22.7%-32.2%
Q2 2023-2.3%+2.7%-84.1%
Q1 2023+0.6%-7.3%-23.1%
Q4 2022-8.8%-13.5%-34.7%
Q3 2022-13.9%+35.1%+13.9%
Q2 2022+2.5%+23.3%-51.2%
Q1 2022-9.0%-14.2%-1.7%
Q4 2021-2.9%-12.1%+30.6%
Q3 2021+8.1%-4.1%-22.4%
Q2 2021+3.4%+2.4%+45.0%
Q1 2021-1.9%+9.6%+422.5%
Q4 2020-6.2%+33.7%-10.3%
Q3 2020-8.9%+5.5%+83.1%
Q2 2020-0.2%+9.9%+69.2%
Q1 2020-7.1%-8.7%-29.1%
Q4 2019+31.1%+30.3%+85.2%
Q3 2019-4.6%-4.2%-16.9%
Q2 2019+5.8%+2.8%+1.5%
Q1 2019-7.0%-7.8%-26.6%
Q4 2018+1.2%+12.6%+7.1%
Q3 2018-1.4%-15.5%-22.4%
Q2 2018-1.5%+6.1%+16.9%
Q1 2018+5.5%+0.0%-9.8%
Q4 2017-1.7%+6.3%-6.3%
Q3 2017+2.5%-7.6%+19.7%
Q2 2017+7.6%+2.6%-6.3%
Q1 2017-1.0%-7.6%-18.4%
Q4 2016-0.3%-6.5%-1.0%
Q3 2016+2.6%+10.2%+4.3%
Q2 2016-3.3%-1.3%+3.4%
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2013
Q2 2014
Q4 2012
Q1 2013
Q1 2014
Q4 2013
Q3 2013
Q3 2012

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro